Drugs / Alginate oligosaccharide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT02453789 Comparator | Feb 2015 → Mar 2017 | burkholderia infectious disease, cystic fibrosis | AlgiPharma AS | Completed | No outcome recorded |
| Phase 2 | NCT02157922 Comparator | Oct 2014 → Jan 2017 | cystic fibrosis | AlgiPharma AS | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alginate oligosaccharide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02453789 ↗ |